ROHTESH S MEHTA to Stem Cell Transplantation
This is a "connection" page, showing publications ROHTESH S MEHTA has written about Stem Cell Transplantation.
Connection Strength
0.560
-
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification. Am J Hematol. 2022 03 01; 97(3):329-337.
Score: 0.120
-
Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant. Clin Cancer Res. 2021 11 01; 27(21):5847-5856.
Score: 0.116
-
Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma. Biol Blood Marrow Transplant. 2019 07; 25(7):1340-1346.
Score: 0.098
-
Cord Blood Expansion: A Clinical Advance. J Clin Oncol. 2019 02 10; 37(5):363-366.
Score: 0.097
-
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs. Bone Marrow Transplant. 2019 07; 54(7):1089-1093.
Score: 0.096
-
Endophthalmitis, Cutaneous Nodules, and Brain Lesions in Stem Cell Transplant Recipient. Clin Infect Dis. 2023 10 13; 77(8):1212-1215.
Score: 0.034